The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...

Goldman Sachs Group Inc. is wading back into the market for SPACs three years after stricter regulatory scrutiny prompted a self-imposed ban on handling so-called blank-check companies. The investment ...

Wall Street legend Leon Cooperman revealed his outlook for stocks and the economy, hailed Warren Buffett, and shared how he ...

Investing.com -- Goldman Sachs Group Inc. (NYSE: GS) has decided to re-enter the special-purpose acquisition company (SPAC) market, ending a self-imposed ban that began three years ago when regulatory ...

A look at Warburg Pincus’ recent sale of Sundyne to Honeywell; Clearview Capital announced the sale of Result Partners, a ...